Prolia (denosumab) - Amgen
Evenity (romosozumab-aqqg) - Astellas, Amgen, UCB
Comparative Effectiveness of Sequential Romosozumab-Denosumab vs. Denosumab Alone on Fracture Risk: A Target Trial Emulation Study (ACR Convergence 2026) - Sep 8, 2026 - Abstract #1562; Pres time: Nov 9, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available 
HEOR • Musculoskeletal Diseases • Orthopedics
https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3568626
 
Ye Liu, MD, MPH, DrPH
 
Sep 8, 2026
 
Prev Next